|Articles|March 1, 2001

New developments in maternal fetal medicine

The 2001 annual meeting of the Society for Maternal-Fetal Medicine offered a wide array of important research findings--and new clinical implications--on tocolysis, thrombophilia, cerclage, antenatal steroid therapy, and group B streptocccal infection.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Transabdominal cerclage linked to lower preterm birth vs transvaginal cerclage

ByContemporary OB/GYN Staff

December 15th 2025

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

ByMorgan Ebert, Managing Editor

December 15th 2025

Heavy menstrual bleeding linked to iron deficiency in adolescents

ByCeleste Krewson, Assistant Editor

December 15th 2025

HMI-115 shows promising pain relief in endometriosis patients

ByCeleste Krewson, Assistant Editor

December 14th 2025

High costs and transfusions linked to acute heavy menstrual bleeding

ByCeleste Krewson, Assistant Editor

December 13th 2025

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

New developments in maternal fetal medicine

Newsletter

Related Content

Transabdominal cerclage linked to lower preterm birth vs transvaginal cerclage

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

Heavy menstrual bleeding linked to iron deficiency in adolescents

HMI-115 shows promising pain relief in endometriosis patients

High costs and transfusions linked to acute heavy menstrual bleeding

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

HMI-115 shows promising pain relief in endometriosis patients

Heavy menstrual bleeding linked to iron deficiency in adolescents

Transabdominal cerclage linked to lower preterm birth vs transvaginal cerclage

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea